Mehmet Çimentepe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mehmet Çimentepe has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Metin Yildirim
Department of Biochemistry, Faculty of Pharmacy Cukurova University Adana Türkiye
8 shared publications - Özge Öztürk Çimentepe
Department of Pharmacology, Faculty of Pharmacy, Harran University, Sanliurfa 63300, Türkiye
6 shared publications - Akın Yiğin
Department of Genetics, Faculty of Veterinary Medicine, Harran University, Sanliurfa 63200, Türkiye
5 shared publications - Başak Bedir
Department of Nutrition and Dietetics, Faculty of Health Sciences, Hakkari University, Hakkâri 30000, Türkiye
3 shared publications - Hakan Ünver
Department of Chemistry, Faculty of Science Eskişehir Technical University Eskişehir Türkiye
3 shared publications - Mehmet Erşatır
Department of Chemistry, Faculty of Art and Science, Cukurova University, Adana 01330, Türkiye
3 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (10) , e71828
Integrated Biological Evaluation of Benzimidazolium–Chalcone Derivatives: Antioxidant, Anti‐AChE, Anticancer, and Anti‐MRSA Activities With Docking Insights
Four new benzimidazolium–chalcone salt derivatives were synthesized and successfully characterized using 1 H NMR, 13 C NMR, and FT‐IR spectroscopy. Their antioxidant activity, acetylcholinesterase (AChE) inhibitory potential, antibacterial and antibiofilm activities against MRSA and MSSA strains, as well as their anticancer and apoptosis‐inducing properties in human colon adenocarcinoma (HT‐29) cells, were comprehensively evaluated. Among the synthesized compounds, 3a exhibited the strongest antioxidant activity, with IC 50 values of 10.13 ± 0.30 µg/mL in the ABTS assay and 79.40 µg/mL in the DPPH assay, and demonstrated the highest AChE inhibitory effect. Molecular docking analysis further supported these findings, revealing a favorable binding affinity of compound 3a toward the 4EY7 target protein, with a docking score of −8.619 kcal/mol. Antibacterial evaluation using the agar well diffusion method showed that compound 3b produced the largest inhibition zone (19.2 ± 0.6 mm). Consistently, MIC analysis confirmed that 3b displayed potent antibacterial activity against MRSA (MIC: 1 µg/mL) and exhibited the most pronounced antibiofilm effect among the tested derivatives. In cytotoxicity assays, compound 3c demonstrated the highest anticancer activity against HT‐29 cells, with an IC 50 value of 16.7 ± 2.09 µM. Apoptosis analysis revealed that 3c predominantly induced early‐stage apoptosis.
- 15 October 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (10) , e71828
Open AccessIntegrated Biological Evaluation of Benzimidazolium–Chalcone Derivatives: Antioxidant, Anti‐AChE, Anticancer, and Anti‐MRSA Activities With Docking Insights
Four new benzimidazolium–chalcone salt derivatives were synthesized and successfully characterized using 1 H NMR, 13 C NMR, and FT‐IR spectroscopy. Their antioxidant activity, acetylcholinesterase (AChE) inhibitory potential, antibacterial and antibiofilm activities against MRSA and MSSA strains, as well as their anticancer and apoptosis‐inducing properties in human colon adenocarcinoma (HT‐29) cells, were comprehensively evaluated. Among the synthesized compounds, 3a exhibited the strongest antioxidant activity, with IC 50 values of 10.13 ± 0.30 µg/mL in the ABTS assay and 79.40 µg/mL in the DPPH assay, and demonstrated the highest AChE inhibitory effect. Molecular docking analysis further supported these findings, revealing a favorable binding affinity of compound 3a toward the 4EY7 target protein, with a docking score of −8.619 kcal/mol. Antibacterial evaluation using the agar well diffusion method showed that compound 3b produced the largest inhibition zone (19.2 ± 0.6 mm). Consistently, MIC analysis confirmed that 3b displayed potent antibacterial activity against MRSA (MIC: 1 µg/mL) and exhibited the most pronounced antibiofilm effect among the tested derivatives. In cytotoxicity assays, compound 3c demonstrated the highest anticancer activity against HT‐29 cells, with an IC 50 value of 16.7 ± 2.09 µM. Apoptosis analysis revealed that 3c predominantly induced early‐stage apoptosis.
- Open Access
- 1 October 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (10) , 1252
Antibacterial, Anti-Inflammatory, and Wound-Healing Effects of Micromeria fruticosa Essential Oil-Loaded Nanoemulsion in MRSA-Infected Diabetic Wounds: In Vitro and In Vivo Evaluation
Background/Objectives: Diabetic foot ulcers infected with methicillin-resistant Staphylococcus aureus (MRSA) heal poorly and respond inadequately to conventional antibiotic therapy. This study developed a Micromeria fruticosa essential oil-loaded nanoemulsion (Mf-NE) as a topical treatment for such wounds. Methods: The essential oil was obtained by hydrodistillation and analyzed by GC–MS. Nanoemulsions were developed from pseudoternary phase diagrams using oleic acid and a Cremophor® EL/Tween 80–Transcutol® system (2:1 surfactant/cosurfactant) and characterized physicochemically. Antibacterial activity against MRSA (ATCC 43300) was assessed by agar well diffusion and microdilution, antioxidant activity by DPPH and ABTS assays, and cytocompatibility by MTT assay on L929 fibroblasts. Efficacy was evaluated over 12 days in a streptozotocin-induced MRSA-infected diabetic wound model in rats. Results: Pulegone (42.81%) and piperitenone (29.73%) were the major constituents. Incorporation of 5% (w/w) essential oil raised the droplet size from 214.5 ± 14.4 to 292.9 ± 9.9 nm; both formulations had a dermatologically acceptable pH and Newtonian flow behavior. Mf-NE produced a 16.1 mm inhibition zone and a MIC of 1.25 mg/mL, whereas NE produced no inhibition zone and had a MIC of 5 mg/mL. Radical scavenging reached 61.5% by DPPH at 10 mg/mL and 71.5% by ABTS at 0.2 mg/mL, and cell viability remained above 87%. The NE and Mf-NE formulations also demonstrated good biocompatibility in L929 fibroblast cells. Topical Mf-NE reduced the remaining wound area to 4.8 ± 0.9% of the initial area by day 12, compared with 21.0 ± 1.9% for Fucidin, 26.1 ± 1.9% for NE and 57.2 ± 1.3% for the untreated group; bacterial colonization was almost completely suppressed, TNF-α and IL-1β expression was significantly decreased, and composite histopathological scores were lower than in the untreated group (p = 0.0007). Conclusions: Mf-NE is a promising topical candidate for MRSA-infected diabetic wounds. Formulation-specific dermal and systemic safety requires further evaluation.
- 1 October 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (10) , 1252
Open AccessAntibacterial, Anti-Inflammatory, and Wound-Healing Effects of Micromeria fruticosa Essential Oil-Loaded Nanoemulsion in MRSA-Infected Diabetic Wounds: In Vitro and In Vivo Evaluation
Background/Objectives: Diabetic foot ulcers infected with methicillin-resistant Staphylococcus aureus (MRSA) heal poorly and respond inadequately to conventional antibiotic therapy. This study developed a Micromeria fruticosa essential oil-loaded nanoemulsion (Mf-NE) as a topical treatment for such wounds. Methods: The essential oil was obtained by hydrodistillation and analyzed by GC–MS. Nanoemulsions were developed from pseudoternary phase diagrams using oleic acid and a Cremophor® EL/Tween 80–Transcutol® system (2:1 surfactant/cosurfactant) and characterized physicochemically. Antibacterial activity against MRSA (ATCC 43300) was assessed by agar well diffusion and microdilution, antioxidant activity by DPPH and ABTS assays, and cytocompatibility by MTT assay on L929 fibroblasts. Efficacy was evaluated over 12 days in a streptozotocin-induced MRSA-infected diabetic wound model in rats. Results: Pulegone (42.81%) and piperitenone (29.73%) were the major constituents. Incorporation of 5% (w/w) essential oil raised the droplet size from 214.5 ± 14.4 to 292.9 ± 9.9 nm; both formulations had a dermatologically acceptable pH and Newtonian flow behavior. Mf-NE produced a 16.1 mm inhibition zone and a MIC of 1.25 mg/mL, whereas NE produced no inhibition zone and had a MIC of 5 mg/mL. Radical scavenging reached 61.5% by DPPH at 10 mg/mL and 71.5% by ABTS at 0.2 mg/mL, and cell viability remained above 87%. The NE and Mf-NE formulations also demonstrated good biocompatibility in L929 fibroblast cells. Topical Mf-NE reduced the remaining wound area to 4.8 ± 0.9% of the initial area by day 12, compared with 21.0 ± 1.9% for Fucidin, 26.1 ± 1.9% for NE and 57.2 ± 1.3% for the untreated group; bacterial colonization was almost completely suppressed, TNF-α and IL-1β expression was significantly decreased, and composite histopathological scores were lower than in the untreated group (p = 0.0007). Conclusions: Mf-NE is a promising topical candidate for MRSA-infected diabetic wounds. Formulation-specific dermal and systemic safety requires further evaluation.
- Open Access
- 30 September 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (10) , 1242
Green-Synthesized Rheum cordatum Root-Based Carbon Nanosphere-Based ZIF-8 Nanocomposite Against MRSA: In Vitro Antioxidant, Antibacterial Activity and Gene Expression Profiling
Background & Aim: The emergence of multidrug-resistant pathogens, particularly methicillin-resistant Staphylococcus aureus (MRSA), necessitates the development of novel antimicrobial strategies. Green synthesis approaches and composite nanomaterials have attracted considerable attention as promising alternatives to conventional antimicrobial agents. Therefore, this study aimed to synthesize a carbon nanosphere/zeolitic imidazolate framework-8 (CNS@ZIF-8) nanocomposite using Rheum cordatum Losinsk. root-derived carbon nanospheres and to evaluate its antioxidant, antibacterial, antibiofilm, and anti-virulence properties against MRSA and methicillin-sensitive S. aureus (MSSA). Methods: Carbon nanospheres (CNS) were green-synthesized from the roots of Rheum cordatum Losinsk. and subsequently integrated with ZIF-8 to fabricate the CNS@ZIF-8 nanocomposite. The synthesized materials were characterized using UV–Vis spectroscopy, Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), and X-ray diffraction (XRD). Antioxidant activity was assessed using DPPH and ABTS radical scavenging assays. Antibacterial activity was evaluated by determining the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). Antibiofilm activity, SEM-based bacterial morphology analysis, and quantitative real-time PCR of virulence- and resistance-associated genes (icaA, dltA, dltB, mepA, and norA) were also performed. Results: Characterization analyses confirmed the successful synthesis of the CNS@ZIF-8 nanocomposite. CNS@ZIF-8 exhibited antibacterial activity against both MRSA and MSSA, with MIC and MBC values of 128 and 256 µg/mL, respectively. SEM analysis revealed severe membrane disruption and morphological damage in treated bacterial cells. Gene expression analysis demonstrated significant downregulation of biofilm formation-, cell wall modification-, and efflux pump-associated genes. CNS@ZIF-8 also showed enhanced antioxidant activity compared with pristine ZIF-8, with IC50 values of 45.1 ± 0.55 µg/mL (DPPH) and 9.1 ± 0.44 µg/mL (ABTS), whereas ZIF-8 exhibited IC50 values of 149.2 ± 0.32 and 22.3 ± 0.31 µg/mL, respectively. However, CNS alone displayed the strongest radical scavenging activity. The antioxidant standard butylated hydroxytoluene (BHT) exhibited IC50 values of 23.4 ± 0.42 µg/mL (DPPH) and 26.3 ± 0.63 µg/mL (ABTS). Conclusion: The CNS@ZIF-8 nanocomposite demonstrated promising antioxidant, antibacterial, antibiofilm, and anti-virulence activities against S. aureus, particularly MRSA. These findings suggest that CNS@ZIF-8 represents a multifunctional nanomaterial with potential for the development of alternative therapeutic strategies against multidrug-resistant bacterial infections.
- 30 September 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (10) , 1242
Open AccessGreen-Synthesized Rheum cordatum Root-Based Carbon Nanosphere-Based ZIF-8 Nanocomposite Against MRSA: In Vitro Antioxidant, Antibacterial Activity and Gene Expression Profiling
Background & Aim: The emergence of multidrug-resistant pathogens, particularly methicillin-resistant Staphylococcus aureus (MRSA), necessitates the development of novel antimicrobial strategies. Green synthesis approaches and composite nanomaterials have attracted considerable attention as promising alternatives to conventional antimicrobial agents. Therefore, this study aimed to synthesize a carbon nanosphere/zeolitic imidazolate framework-8 (CNS@ZIF-8) nanocomposite using Rheum cordatum Losinsk. root-derived carbon nanospheres and to evaluate its antioxidant, antibacterial, antibiofilm, and anti-virulence properties against MRSA and methicillin-sensitive S. aureus (MSSA). Methods: Carbon nanospheres (CNS) were green-synthesized from the roots of Rheum cordatum Losinsk. and subsequently integrated with ZIF-8 to fabricate the CNS@ZIF-8 nanocomposite. The synthesized materials were characterized using UV–Vis spectroscopy, Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), and X-ray diffraction (XRD). Antioxidant activity was assessed using DPPH and ABTS radical scavenging assays. Antibacterial activity was evaluated by determining the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). Antibiofilm activity, SEM-based bacterial morphology analysis, and quantitative real-time PCR of virulence- and resistance-associated genes (icaA, dltA, dltB, mepA, and norA) were also performed. Results: Characterization analyses confirmed the successful synthesis of the CNS@ZIF-8 nanocomposite. CNS@ZIF-8 exhibited antibacterial activity against both MRSA and MSSA, with MIC and MBC values of 128 and 256 µg/mL, respectively. SEM analysis revealed severe membrane disruption and morphological damage in treated bacterial cells. Gene expression analysis demonstrated significant downregulation of biofilm formation-, cell wall modification-, and efflux pump-associated genes. CNS@ZIF-8 also showed enhanced antioxidant activity compared with pristine ZIF-8, with IC50 values of 45.1 ± 0.55 µg/mL (DPPH) and 9.1 ± 0.44 µg/mL (ABTS), whereas ZIF-8 exhibited IC50 values of 149.2 ± 0.32 and 22.3 ± 0.31 µg/mL, respectively. However, CNS alone displayed the strongest radical scavenging activity. The antioxidant standard butylated hydroxytoluene (BHT) exhibited IC50 values of 23.4 ± 0.42 µg/mL (DPPH) and 26.3 ± 0.63 µg/mL (ABTS). Conclusion: The CNS@ZIF-8 nanocomposite demonstrated promising antioxidant, antibacterial, antibiofilm, and anti-virulence activities against S. aureus, particularly MRSA. These findings suggest that CNS@ZIF-8 represents a multifunctional nanomaterial with potential for the development of alternative therapeutic strategies against multidrug-resistant bacterial infections.
- Open Access
- 24 September 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (10) , 951
Synthesis and Characterization of Silibinin-Loaded ZIF-8 Nanocomposites and Their Antibacterial Activity Against Escherichia coli: Insights into acrB, recA, and htpX Gene Expression
Background/Objectives: In this study, ZIF-8 and silibinin-loaded ZIF-8 nanostructures containing different concentrations of silibinin were successfully synthesized using a one-pot method and characterized by FT-IR, SEM, and EDX analyses. Methods: The antibacterial activities of the synthesized nanostructures were subsequently evaluated against Escherichia coli, Escherichia coli O157:H7, Salmonella Typhimurium, and Listeria monocytogenes using the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays. Results: Among all tested formulations, S2@ZIF-8 exhibited the strongest antibacterial activity against E. coli, with an MIC of 32 μg/mL and an MBC of 64 μg/mL. In the agar well diffusion assay, S2@ZIF-8 produced an inhibition zone of 12.1 ± 0.35 mm. The antibiofilm activity evaluated at the MIC revealed inhibition rates of 52.6 ± 0.50%, 33.5 ± 0.50%, and 29.9 ± 0.17% for S2@ZIF-8, S1@ZIF-8, and pristine ZIF-8, respectively. Furthermore, gene expression analysis demonstrated that S2@ZIF-8 exerted a marked inhibitory effect on acrB and htpX gene expression, while producing a comparatively moderate suppressive effect on recA. Conclusions: Overall, S2@ZIF-8 exhibited superior antibacterial and antibiofilm activity among the tested formulations.
- 24 September 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (10) , 951
Open AccessSynthesis and Characterization of Silibinin-Loaded ZIF-8 Nanocomposites and Their Antibacterial Activity Against Escherichia coli: Insights into acrB, recA, and htpX Gene Expression
Background/Objectives: In this study, ZIF-8 and silibinin-loaded ZIF-8 nanostructures containing different concentrations of silibinin were successfully synthesized using a one-pot method and characterized by FT-IR, SEM, and EDX analyses. Methods: The antibacterial activities of the synthesized nanostructures were subsequently evaluated against Escherichia coli, Escherichia coli O157:H7, Salmonella Typhimurium, and Listeria monocytogenes using the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays. Results: Among all tested formulations, S2@ZIF-8 exhibited the strongest antibacterial activity against E. coli, with an MIC of 32 μg/mL and an MBC of 64 μg/mL. In the agar well diffusion assay, S2@ZIF-8 produced an inhibition zone of 12.1 ± 0.35 mm. The antibiofilm activity evaluated at the MIC revealed inhibition rates of 52.6 ± 0.50%, 33.5 ± 0.50%, and 29.9 ± 0.17% for S2@ZIF-8, S1@ZIF-8, and pristine ZIF-8, respectively. Furthermore, gene expression analysis demonstrated that S2@ZIF-8 exerted a marked inhibitory effect on acrB and htpX gene expression, while producing a comparatively moderate suppressive effect on recA. Conclusions: Overall, S2@ZIF-8 exhibited superior antibacterial and antibiofilm activity among the tested formulations.
- 1 September 2026
- Published by Igdir University in Journal of the Institute of Science and Technology
- Vol. 16 (3) , 936-948
Carthamus tinctorius L. Ekstresi ile Sentezlenen Çinko Oksit Nanopartiküllerin Antioksidan, Antikanser, Antibakteriyel ve Antibiyofilm Aktivitelerinin Değerlendirilmesi
Bu çalışmada, Carthamus tinctorius L. su ekstresi kullanılarak kolay ve çevre dostu bir yöntemle çinko oksit nanopartiküller (A@ZnO) sentezlenmiştir. Taramalı elektron mikroskop (SEM) ve Fourier dönüşümlü kızılötesi (FTIR) teknikleri kullanılarak elde edilen nanopartiküllerin yapısal ve kimyasal karakterizasyonu yapılmıştır. Karakterize edilen A@ZnO nanopartiküllerinin, antioksidan, antikanser, antibakteriyel ve antibiyofilm aktivitesi/kapasitesi incelenmiştir. FTIR spektrumları, çinko oksit iyonlarının indirgenmesinde rol oynayan fonksiyonel grupları belirlemiştir. SEM analizi, A@ZnO nanopartiküllerinin küresel bir morfolojiye sahip olduğunu ve yüksek pürüzlülük gösterdiğini ortaya koymuştur. Farklı konsantrasyonlardaki A@ZnO nanopartiküllerin serbest radikal temizleme potansiyeli, 2,2'-azino-bis (3-etilbenzotiyazolin-6-sülfonik asit (ABTS)) testinde 1 mg/mL’de %97.9 ± 1 oranında antioksidan inhibisyon ve 0.386 mg/mL konsantrasyonda IC50 değeri göstermiştir. Antikanser aktivite testinde, A@ZnO’nin A549 ve HEp-2 kanser hücresine 500 µg/mL konsantrasyonda %2.1 ± 0.21 ve %6.6 ± 1.1 oranlarında hücre canlılığı görülmüştür. Her iki kanser hücresinde görülen IC50 değerleri sırası ile 187.3 ± 7.1 µg/mL ve 185.4 ± 7.3 µg/mL olarak tespit edilmiştir. A@ZnO nanopartikülleri MSSA ve MRSA suşlarına karşı minimum inhibitör konsantrasyon (MİK) değeri 128 µg/mL ve 32 µg/mL olarak bulunmuştur. Ayrıca MRSA suşuna karşı doza bağımlı bir şekilde antibiyofilm aktivitesi gözlenmiştir. Elde edilen bulgular aspir su ekstresi kullanılarak gerçekleştirilen A@ZnO nanopartiküllerin, sergiledikleri antioksidan, antikanser, antibakteriyel ve antibiyofilm aktiviteler sayesinde biyomedikal alanlarda kullanılabilecek önemli bir potansiyel ortaya koymaktadır.
- 1 September 2026
- Published by Igdir University in Journal of the Institute of Science and Technology
- Vol. 16 (3) , 936-948
Carthamus tinctorius L. Ekstresi ile Sentezlenen Çinko Oksit Nanopartiküllerin Antioksidan, Antikanser, Antibakteriyel ve Antibiyofilm Aktivitelerinin Değerlendirilmesi
Bu çalışmada, Carthamus tinctorius L. su ekstresi kullanılarak kolay ve çevre dostu bir yöntemle çinko oksit nanopartiküller (A@ZnO) sentezlenmiştir. Taramalı elektron mikroskop (SEM) ve Fourier dönüşümlü kızılötesi (FTIR) teknikleri kullanılarak elde edilen nanopartiküllerin yapısal ve kimyasal karakterizasyonu yapılmıştır. Karakterize edilen A@ZnO nanopartiküllerinin, antioksidan, antikanser, antibakteriyel ve antibiyofilm aktivitesi/kapasitesi incelenmiştir. FTIR spektrumları, çinko oksit iyonlarının indirgenmesinde rol oynayan fonksiyonel grupları belirlemiştir. SEM analizi, A@ZnO nanopartiküllerinin küresel bir morfolojiye sahip olduğunu ve yüksek pürüzlülük gösterdiğini ortaya koymuştur. Farklı konsantrasyonlardaki A@ZnO nanopartiküllerin serbest radikal temizleme potansiyeli, 2,2'-azino-bis (3-etilbenzotiyazolin-6-sülfonik asit (ABTS)) testinde 1 mg/mL’de %97.9 ± 1 oranında antioksidan inhibisyon ve 0.386 mg/mL konsantrasyonda IC50 değeri göstermiştir. Antikanser aktivite testinde, A@ZnO’nin A549 ve HEp-2 kanser hücresine 500 µg/mL konsantrasyonda %2.1 ± 0.21 ve %6.6 ± 1.1 oranlarında hücre canlılığı görülmüştür. Her iki kanser hücresinde görülen IC50 değerleri sırası ile 187.3 ± 7.1 µg/mL ve 185.4 ± 7.3 µg/mL olarak tespit edilmiştir. A@ZnO nanopartikülleri MSSA ve MRSA suşlarına karşı minimum inhibitör konsantrasyon (MİK) değeri 128 µg/mL ve 32 µg/mL olarak bulunmuştur. Ayrıca MRSA suşuna karşı doza bağımlı bir şekilde antibiyofilm aktivitesi gözlenmiştir. Elde edilen bulgular aspir su ekstresi kullanılarak gerçekleştirilen A@ZnO nanopartiküllerin, sergiledikleri antioksidan, antikanser, antibakteriyel ve antibiyofilm aktiviteler sayesinde biyomedikal alanlarda kullanılabilecek önemli bir potansiyel ortaya koymaktadır.
- Open Access
- 2 June 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (6) , 567
Integrated In Vitro and In Silico Evaluation of Benzimidazolium Salts: Antioxidant Activity, Anti-MRSA/MSSA Effects, and Antibacterial Gene Expression Analysis
Background/Objectives: The emergence of methicillin-resistant Staphylococcus aureus (MRSA) has created an urgent need for the development of novel antimicrobial agents. This study aimed to synthesize and characterize a series of benzimidazolium salts and evaluate their antibacterial, antibiofilm, and molecular interaction properties against MRSA and methicillin-susceptible Staphylococcus aureus (MSSA). Methods: Five benzimidazolium salts bearing different substituents were synthesized and characterized by NMR and FTIR analyses. Their antibacterial activities against MRSA and MSSA were investigated using the resazurin-based minimum inhibitory concentration (MIC) assay and agar diffusion method. Antibiofilm activity was evaluated using crystal violet staining, while scanning electron microscopy (SEM) was employed to examine bacterial morphological changes. Gene expression analysis was performed to assess the effects of the most active compound on virulence- and resistance-related genes. In addition, molecular docking studies were conducted against four target proteins (1MWT, 3ZG5, 1JIJ, and 2Y2M). Results: Among the synthesized compounds, compound 1c exhibited the strongest antibacterial activity, with MIC values of 0.25 µg/mL against MRSA and 0.5 µg/mL against MSSA. It also produced the largest inhibition zone diameter (31.0 ± 0.5 mm). SEM analysis revealed significant morphological alterations in treated bacterial cells, indicating disruption of cellular integrity. Gene expression studies demonstrated that compound 1c downregulated several virulence- and resistance-associated genes, including icaA, dltA, dltB, sarA, norA, and norB. All compounds displayed antibiofilm activity, with compound 1c showing the highest inhibition rate (68.6 ± 0.6%). Molecular docking analysis revealed that compound 1c exhibited the strongest binding affinity toward the 2Y2M target protein, with a docking score of −5.322 kcal/mol. Conclusions: The findings demonstrate that benzimidazolium derivatives, particularly compound 1c, possess potent antibacterial and antibiofilm activities against S. aureus strains and effectively modulate virulence- and resistance-related gene expression. Combined with favorable molecular docking results, these compounds represent promising candidates for the development of new therapeutic agents against resistant S. aureus infections.
- 2 June 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (6) , 567
Open AccessIntegrated In Vitro and In Silico Evaluation of Benzimidazolium Salts: Antioxidant Activity, Anti-MRSA/MSSA Effects, and Antibacterial Gene Expression Analysis
Background/Objectives: The emergence of methicillin-resistant Staphylococcus aureus (MRSA) has created an urgent need for the development of novel antimicrobial agents. This study aimed to synthesize and characterize a series of benzimidazolium salts and evaluate their antibacterial, antibiofilm, and molecular interaction properties against MRSA and methicillin-susceptible Staphylococcus aureus (MSSA). Methods: Five benzimidazolium salts bearing different substituents were synthesized and characterized by NMR and FTIR analyses. Their antibacterial activities against MRSA and MSSA were investigated using the resazurin-based minimum inhibitory concentration (MIC) assay and agar diffusion method. Antibiofilm activity was evaluated using crystal violet staining, while scanning electron microscopy (SEM) was employed to examine bacterial morphological changes. Gene expression analysis was performed to assess the effects of the most active compound on virulence- and resistance-related genes. In addition, molecular docking studies were conducted against four target proteins (1MWT, 3ZG5, 1JIJ, and 2Y2M). Results: Among the synthesized compounds, compound 1c exhibited the strongest antibacterial activity, with MIC values of 0.25 µg/mL against MRSA and 0.5 µg/mL against MSSA. It also produced the largest inhibition zone diameter (31.0 ± 0.5 mm). SEM analysis revealed significant morphological alterations in treated bacterial cells, indicating disruption of cellular integrity. Gene expression studies demonstrated that compound 1c downregulated several virulence- and resistance-associated genes, including icaA, dltA, dltB, sarA, norA, and norB. All compounds displayed antibiofilm activity, with compound 1c showing the highest inhibition rate (68.6 ± 0.6%). Molecular docking analysis revealed that compound 1c exhibited the strongest binding affinity toward the 2Y2M target protein, with a docking score of −5.322 kcal/mol. Conclusions: The findings demonstrate that benzimidazolium derivatives, particularly compound 1c, possess potent antibacterial and antibiofilm activities against S. aureus strains and effectively modulate virulence- and resistance-related gene expression. Combined with favorable molecular docking results, these compounds represent promising candidates for the development of new therapeutic agents against resistant S. aureus infections.
- Open Access
- 8 May 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (5) , 477
Antibacterial and Antibiofilm Potential of Thymol–Benzimidazolium–Chalcone Hybrids Against Clinical MRSA Strains: Insights from Gene Expression Profiling and Molecular Docking
Background/Objectives: Four novel thymol–benzimidazolium–chalcone hybrids were designed based on a molecular hybridization strategy that integrates bioactive scaffolds known for their antimicrobial and antioxidant properties. This approach aims to enhance biological activity through synergistic effects and multi-target interactions, as supported by previous studies on phenolic and benzimidazole derivatives. The inclusion of both antioxidant and antibacterial evaluations was motivated by the well-established role of oxidative stress in bacterial pathogenicity and resistance mechanisms. Methods: Their antibacterial potential was initially screened using the disk diffusion method and subsequently evaluated by determining MIC and MBC values against eight clinical Staphylococcus aureus isolates. Results: Among the tested compounds, compound 3a emerged as the most potent derivative, exhibiting MIC values ranging from 0.25 to 1 µg/mL. Morphological analysis confirmed significant disruption of bacterial cell integrity, and further investigation demonstrated strong antibiofilm activity accompanied by downregulation of key biofilm- and resistance-associated genes (icaA, dltB, and mepA). Molecular docking studies were performed against selected target proteins, including 1MWT, 3VSL, 3ZG5 (sortase A), and 2ZCS, which are associated with bacterial cell wall biosynthesis, DNA replication, virulence, and metabolic pathways. Compound 3a exhibited the highest binding affinity, with a docking score of −11.953 kcal/mol against 2ZCS. Conclusions: Overall, these findings highlight the potential of thymol-based benzimidazolium–chalcone hybrids as promising multifunctional agents with combined antibacterial, antibiofilm, and antioxidant properties.
- 8 May 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (5) , 477
Open AccessAntibacterial and Antibiofilm Potential of Thymol–Benzimidazolium–Chalcone Hybrids Against Clinical MRSA Strains: Insights from Gene Expression Profiling and Molecular Docking
Background/Objectives: Four novel thymol–benzimidazolium–chalcone hybrids were designed based on a molecular hybridization strategy that integrates bioactive scaffolds known for their antimicrobial and antioxidant properties. This approach aims to enhance biological activity through synergistic effects and multi-target interactions, as supported by previous studies on phenolic and benzimidazole derivatives. The inclusion of both antioxidant and antibacterial evaluations was motivated by the well-established role of oxidative stress in bacterial pathogenicity and resistance mechanisms. Methods: Their antibacterial potential was initially screened using the disk diffusion method and subsequently evaluated by determining MIC and MBC values against eight clinical Staphylococcus aureus isolates. Results: Among the tested compounds, compound 3a emerged as the most potent derivative, exhibiting MIC values ranging from 0.25 to 1 µg/mL. Morphological analysis confirmed significant disruption of bacterial cell integrity, and further investigation demonstrated strong antibiofilm activity accompanied by downregulation of key biofilm- and resistance-associated genes (icaA, dltB, and mepA). Molecular docking studies were performed against selected target proteins, including 1MWT, 3VSL, 3ZG5 (sortase A), and 2ZCS, which are associated with bacterial cell wall biosynthesis, DNA replication, virulence, and metabolic pathways. Compound 3a exhibited the highest binding affinity, with a docking score of −11.953 kcal/mol against 2ZCS. Conclusions: Overall, these findings highlight the potential of thymol-based benzimidazolium–chalcone hybrids as promising multifunctional agents with combined antibacterial, antibiofilm, and antioxidant properties.
- Open Access
- 22 December 2025
- Published by Mersin Universitesi Saglik Bilimleri Dergisi in Mersin Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 18 (3) , 494-505
Sideritis brevidens P.H. Davis türünün yeşil sentez yöntemi ile ekstraksiyonu: çoklu ilaç direnci gösteren bakterilere karşı antimikrobiyal ve antibiyofilm aktivitelerinin belirlenmesi
Amaç: Bu çalışmada, süperkritik CO2 (ScCO2) ekstraksiyon ve farklı çözücüler kullanılarak soxhlet ekstraksiyon yöntemlerinden elde edilen Sideritis brevidens’in toprak üstü ekstrelerini incelemeyi, fitokimyasal bileşimlerini karakterize etmeyi ve çoklu ilaç dirençli bakterilere karşı antimikrobiyal ve antibiyofim aktivitelerini değerlendirilmesi amaçlanmıştır. Yöntem: Farklı yöntemler ile elde edilen ekstrelerin fitokimyasal içeriği LC-MS/MS tekniği kullanılarak analiz edilmiştir. Ekstrelerin karbapenem dirençli Acinetobacter baumannii, Escherichia coli ve Klebsiella pneumoniae ile metisillin dirençli Staphylococcus aureus suşlarına karşı antibakteriyel etkinlikleri mikrodilüsyon yöntemi araştırılmıştır. Ayrıca, ekstrelerin Acinetobacter baumannii suşuna karşı antibiyofilm aktiviteleri kristal viyole yöntemi ile değerlendirilmiştir. Bulgular: Sideritis brevidens’in farklı yöntemler ile elde edilen ekstrelerinden elde edilen önemli fenolik bileşiklerin çoğu, ScCO2 ekstraksiyon yöntemi kullanılarak tespit edilmiştir. Gallik asit ve kuersetin sadece ScCO2-100 ve ScCO2-200'lü ekstrelerinde bulunmuştur. Buna karşın, klorojenik asit etanollü ve sulu ekstresinde yüksek miktarlarda bulunmuştur. Test edilen suşlar arasında ScCO2-200 ekstresinin 16 µg/mL konsantrasyonunda, özellikle Acinetobacter baumannii ve metisiline dirençli Staphylococcus aureus suşlarına karşı en düşük MİK değeri tespit edilmiştir. Disk difüzyon yöntemine göre, ScCO2-100 ve ScCO2-200'lü ekstresinde Acinetobacter baumannii suşuna karşı en geniş zon çapı (22 mm) görülmüştür. Ayrıca ScCO2-100 ve ScCO2-200’lü ekstresi Acinetobacter baumannii suşuna karşı konsantrasyona bağlı önemli antibiyofilm aktivite sergilemiştir. Sonuç: Bu bulgular, Sideritis brevidens’in çoklu ilaç direnci gösteren bakteriyel enfeksiyonlara doğal bir antimikrobiyal ve antibiyofilm ajan kaynağı olarak önemli potansiyelini vurgulamaktadır. ScCO2 ekstraksiyonu, biyoaktif fitokimyasalların seçici olarak elde edilmesinde önemli avantajlar sunmaktadır.
- 22 December 2025
- Published by Mersin Universitesi Saglik Bilimleri Dergisi in Mersin Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 18 (3) , 494-505
Open AccessSideritis brevidens P.H. Davis türünün yeşil sentez yöntemi ile ekstraksiyonu: çoklu ilaç direnci gösteren bakterilere karşı antimikrobiyal ve antibiyofilm aktivitelerinin belirlenmesi
Amaç: Bu çalışmada, süperkritik CO2 (ScCO2) ekstraksiyon ve farklı çözücüler kullanılarak soxhlet ekstraksiyon yöntemlerinden elde edilen Sideritis brevidens’in toprak üstü ekstrelerini incelemeyi, fitokimyasal bileşimlerini karakterize etmeyi ve çoklu ilaç dirençli bakterilere karşı antimikrobiyal ve antibiyofim aktivitelerini değerlendirilmesi amaçlanmıştır. Yöntem: Farklı yöntemler ile elde edilen ekstrelerin fitokimyasal içeriği LC-MS/MS tekniği kullanılarak analiz edilmiştir. Ekstrelerin karbapenem dirençli Acinetobacter baumannii, Escherichia coli ve Klebsiella pneumoniae ile metisillin dirençli Staphylococcus aureus suşlarına karşı antibakteriyel etkinlikleri mikrodilüsyon yöntemi araştırılmıştır. Ayrıca, ekstrelerin Acinetobacter baumannii suşuna karşı antibiyofilm aktiviteleri kristal viyole yöntemi ile değerlendirilmiştir. Bulgular: Sideritis brevidens’in farklı yöntemler ile elde edilen ekstrelerinden elde edilen önemli fenolik bileşiklerin çoğu, ScCO2 ekstraksiyon yöntemi kullanılarak tespit edilmiştir. Gallik asit ve kuersetin sadece ScCO2-100 ve ScCO2-200'lü ekstrelerinde bulunmuştur. Buna karşın, klorojenik asit etanollü ve sulu ekstresinde yüksek miktarlarda bulunmuştur. Test edilen suşlar arasında ScCO2-200 ekstresinin 16 µg/mL konsantrasyonunda, özellikle Acinetobacter baumannii ve metisiline dirençli Staphylococcus aureus suşlarına karşı en düşük MİK değeri tespit edilmiştir. Disk difüzyon yöntemine göre, ScCO2-100 ve ScCO2-200'lü ekstresinde Acinetobacter baumannii suşuna karşı en geniş zon çapı (22 mm) görülmüştür. Ayrıca ScCO2-100 ve ScCO2-200’lü ekstresi Acinetobacter baumannii suşuna karşı konsantrasyona bağlı önemli antibiyofilm aktivite sergilemiştir. Sonuç: Bu bulgular, Sideritis brevidens’in çoklu ilaç direnci gösteren bakteriyel enfeksiyonlara doğal bir antimikrobiyal ve antibiyofilm ajan kaynağı olarak önemli potansiyelini vurgulamaktadır. ScCO2 ekstraksiyonu, biyoaktif fitokimyasalların seçici olarak elde edilmesinde önemli avantajlar sunmaktadır.
- Open Access
Green Extraction Strategies and Bioactivity of Rheum cordatum Losinsk: Antioxidant, Antimicrobial, and Molecular Docking Insights
This study aimed to compare the efficiency of different green extraction methods for obtaining bioactive compounds from the roots of Rheum cordatum Losinsk and to evaluate their antioxidant and antimicrobial properties. The presence of some important phytochemicals in the extracts obtained using ultrasound-assisted extraction (UAE), subcritical ethanol extraction (Sbc-EtOH), and supercritical CO2 (ScCO2) extraction was determined by LC-MS/MS, and their antioxidant and antimicrobial properties were examined against Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa, and Escherichia coli. The goal was to determine the optimal extraction conditions that maximize the yield of bioactive compounds while preserving their biological properties. Different pressures (100 bar and 400 bar) were tested in UAE extraction, different solvents and times were tested in Sbc-EtOH extraction, and different pressures were tested in ScCO2 extraction. Most of the 53 important phenolic compounds have been extracted using the ScCO2 extraction method, either exclusively or in the highest amounts. It has been observed that more and higher amounts of phenolic compounds were extracted at lower pressure. The highest antioxidant activity was exhibited by the ScCO2 extracts. Additionally, the ScCO2-100 extract obtained at 100 bar showed strong antimicrobial activity, with a minimum inhibitory concentration (MIC) ranging from 31.25 to 250 μg/mL. Gallic acid, epicatechin gallate, epigallocatechin gallate, and catechin were found in extracts. Additionally, molecular docking studies against the 1QWZ, 2ANQ, 3H77, and 6QXS proteins revealed that epicatechin exhibited docking scores of −6.127, −9.479, −5.836, and −7.067 kcal/mol, respectively.
Open AccessGreen Extraction Strategies and Bioactivity of Rheum cordatum Losinsk: Antioxidant, Antimicrobial, and Molecular Docking Insights
This study aimed to compare the efficiency of different green extraction methods for obtaining bioactive compounds from the roots of Rheum cordatum Losinsk and to evaluate their antioxidant and antimicrobial properties. The presence of some important phytochemicals in the extracts obtained using ultrasound-assisted extraction (UAE), subcritical ethanol extraction (Sbc-EtOH), and supercritical CO2 (ScCO2) extraction was determined by LC-MS/MS, and their antioxidant and antimicrobial properties were examined against Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa, and Escherichia coli. The goal was to determine the optimal extraction conditions that maximize the yield of bioactive compounds while preserving their biological properties. Different pressures (100 bar and 400 bar) were tested in UAE extraction, different solvents and times were tested in Sbc-EtOH extraction, and different pressures were tested in ScCO2 extraction. Most of the 53 important phenolic compounds have been extracted using the ScCO2 extraction method, either exclusively or in the highest amounts. It has been observed that more and higher amounts of phenolic compounds were extracted at lower pressure. The highest antioxidant activity was exhibited by the ScCO2 extracts. Additionally, the ScCO2-100 extract obtained at 100 bar showed strong antimicrobial activity, with a minimum inhibitory concentration (MIC) ranging from 31.25 to 250 μg/mL. Gallic acid, epicatechin gallate, epigallocatechin gallate, and catechin were found in extracts. Additionally, molecular docking studies against the 1QWZ, 2ANQ, 3H77, and 6QXS proteins revealed that epicatechin exhibited docking scores of −6.127, −9.479, −5.836, and −7.067 kcal/mol, respectively.
- Open Access
- 2 July 2023
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 48 (2) , 432-440
Monitoring of cytomegalovirus, Epstein-Barr virus and adenovirus infections in hematopoietic stem cell transplant recipients
Purpose: Haematopoietic stem cell transplant (HSCT) recipients with iatrogenic immunosuppression are high-risk patients for viral infections. The aim of this study was to investigate the incidence of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and adenovirus (ADV) infections in HSCT recipients. Materials and Methods: We prospectively monitored 35 patients aged 0-17 years who had allogeneic (n=30) and autologous (n=5) HSCT by quantitative real-time polymerase chain reaction tests for CMV, EBV, and ADV. The monitoring was performed one week before HSCT and weekly for the first 100 days, once a month up to one year after HSCT. In addition, seropositivity for viruses was analysed by Enzyme-Linked Immuno Sorbent Assay a week before transplantation. Results: Before transplantation, all 35 (100%) patients who underwent HSCT were CMV IgG positive, 30 (85.7% - 95% CI: 74.1%-97.3%) HSCT recipients were found to be EBV IgG positive. CMV infection was found in 24 (80% - 95% CI: 65.7%-94.3%), ADV infection in 11 (36.7% - 95% CI: 19.4%-53.9%) and EBV infection in 8 (26.7% - 95% CI: 10.8%-42.5%) allogeneic HSCT patients. In this group, CMV DNA viral load in 8 (26.7%) patients, of which one (3.3%) coinfected with EBV DNA and one (3.3%) with ADV DNA, was higher than 1000 copies/mL which was required for pre-emptive treatment. Among 5 autologous HSCT recipients, CMV DNA was detected in 2 patients, EBV DNA in 5 and ADV DNA in 2. Pre-emptive treatment was given to 11 (%31.4 - 95% CI: 16%-46.8%; 6 CMV, 2 EBV, 1 ADV, 1 CMV-EBV and 1 CMV-ADV infection) of 35 patients. Thus, the development of viral disease was prevented in 7 (63.6% - 95% CI: 35.2%-92.1%). Of the total 35 patients, only 2 (5.7% - 95% CI: 0.0%-13.4%) died due to viral infection. Conclusion: Early diagnosis of viral infections by prospective monitoring of viral loads in HSCT patients would be effective in preventing morbidity and mortality by ensuring timely initiation of pre-emptive therapy.
- 2 July 2023
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 48 (2) , 432-440
Open AccessMonitoring of cytomegalovirus, Epstein-Barr virus and adenovirus infections in hematopoietic stem cell transplant recipients
Purpose: Haematopoietic stem cell transplant (HSCT) recipients with iatrogenic immunosuppression are high-risk patients for viral infections. The aim of this study was to investigate the incidence of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and adenovirus (ADV) infections in HSCT recipients. Materials and Methods: We prospectively monitored 35 patients aged 0-17 years who had allogeneic (n=30) and autologous (n=5) HSCT by quantitative real-time polymerase chain reaction tests for CMV, EBV, and ADV. The monitoring was performed one week before HSCT and weekly for the first 100 days, once a month up to one year after HSCT. In addition, seropositivity for viruses was analysed by Enzyme-Linked Immuno Sorbent Assay a week before transplantation. Results: Before transplantation, all 35 (100%) patients who underwent HSCT were CMV IgG positive, 30 (85.7% - 95% CI: 74.1%-97.3%) HSCT recipients were found to be EBV IgG positive. CMV infection was found in 24 (80% - 95% CI: 65.7%-94.3%), ADV infection in 11 (36.7% - 95% CI: 19.4%-53.9%) and EBV infection in 8 (26.7% - 95% CI: 10.8%-42.5%) allogeneic HSCT patients. In this group, CMV DNA viral load in 8 (26.7%) patients, of which one (3.3%) coinfected with EBV DNA and one (3.3%) with ADV DNA, was higher than 1000 copies/mL which was required for pre-emptive treatment. Among 5 autologous HSCT recipients, CMV DNA was detected in 2 patients, EBV DNA in 5 and ADV DNA in 2. Pre-emptive treatment was given to 11 (%31.4 - 95% CI: 16%-46.8%; 6 CMV, 2 EBV, 1 ADV, 1 CMV-EBV and 1 CMV-ADV infection) of 35 patients. Thus, the development of viral disease was prevented in 7 (63.6% - 95% CI: 35.2%-92.1%). Of the total 35 patients, only 2 (5.7% - 95% CI: 0.0%-13.4%) died due to viral infection. Conclusion: Early diagnosis of viral infections by prospective monitoring of viral loads in HSCT patients would be effective in preventing morbidity and mortality by ensuring timely initiation of pre-emptive therapy.